2025-08-21
No More Fighting Alone: SCUT's Nano-Adaptor Technology Unites Antibodies in the Fight Against Cancer
In the evolving landscape of tumor immunotherapy, monoclonal antibodies (mAbs) have traditionally operated as solitary warriors, targeting single antigens with limited coordination.